new indications for glp-1 drugs GLP-1-based therapies diabetes, obesity and beyond GLP-1 Medications: Everything You Need

Dual peptides for the treatment of obesity Tirzepatide, a novel dual GIP and GLP-1RA, offers significant insights into its mechanism of action, therapeutic benefits, and clinical applications for the management of T2D and obesity in general practice

NIDDK notes that these medications act on receptors in the brain in ways that help decrease appetite, reduce cravings, and signal fullness

Berthelsen, K.K

[196].Sanofi, Annual Report on Form 20-F 2016, 2017

Pharmacokinetics and discontinuation timing Analysis of pharmacokinetic data highlighted significant variability in half-lives across GLP-1 RAs

Actual eligibility will be determined by Medicare GLP-1 Bridge eligibility criteria